Schaeffer's S&P 500 Index Hot Stocks Features Mylan Laboratories, Kohl's, Coach, Caremark Rx, and C.R. Bard.

CINCINNATI -- Among the stocks featured in the June 1 edition of Schaeffer's S&P 500 Index Hot Stocks are Mylan Laboratories (NYSE:MYL), Kohl's (NYSE:KSS), Coach (NYSE:COH), Caremark Rx (NYSE:CMX), and C.R. Bard (NYSE:BCR). Schaeffer's S&P 500 Index Hot Stocks is just one of the many free market commentaries written everyday at www.SchaeffersResearch.com - the home of Bernie Schaeffer and Schaeffer's Investment Research. For additional information about this report or to have it delivered to you free via email every day click on the following link. http://www.schaeffersresearch.com/redirect.aspx?CODE=PRSHS1M&PAGE=1 .

Schaeffer's S&P 500 Index Hot Stocks for Wednesday, June 1, 2005:

A daily feature available on SchaeffersResearch.com is the "SPX Hot Stocks" column. Each afternoon, we will provide a list of the day's top-20 performing stocks in the S&P 500 Index (SPX - 1,204.33) as well as the bottom-20 names. Featured along with this table will be news that is moving some of the securities.

NOTE: Stocks trading under $5 per share have been eliminated from this listing of the top-20 and bottom-20 performing stocks.

The SPX has surged ahead today, after yesterday's decline, and 88.4 percent of the stocks in the index showed gains at last check.

Mylan Laboratories (NYSE:MYL) is a hot stock today, thanks to twin morsels of good news. In a $5 billion deal, financier Carl Icahn and his affiliate High River L.P., hope to acquire MYL for $20 a share, and the Dow Jones Newswires reports that he wants the company's management to leave it to shareholders to decide whether to accept the offer. Also today, MYL has received an approvable letter from the U.S. Food and Drug Administration for its nebivolol blood-pressure drug.

Kohl's (NYSE:KSS) stock is selling well today after the company announced that May same-store sales rose 0.2 percent and indicated that second-quarter earnings guidance of 49 cents to 52 cents is still the target. The stock gapped up sharply this morning, above key resistance at the 50 level. Best Buy (BBY) also made news, receiving an upgrade from Goldman Sachs to "outperform" from "in-line." Together the stocks gave a noticeable lift to the retail sector's main measure of performance, the S&P Retail Index.

Coach (NYSE:COH) burst through resistance at 30 today to hit an all-time high of 30.75. There is little news from the posh purse producer. On May 11 we learned that the company plans to repurchase $250 million worth of COH stock, and Goldman Sachs reiterated its "outperform" rating. The company's monthly chart since December 2001 shows a textbook case of consistent growth.

Yesterday Denver-based Janus Capital Group (JNS) was near the top of our S&P Hot Stocks, despite appearing on Thomson First Call's Lowest-Rated Stocks list. Last week Bear Stearns initiated coverage on JNS, putting it at "peer perform." After yesterday's strong gains, JNS is retreating a little, though the overall price gain on the week is still looking healthy and the stock appears to be finding support at the 15 level.

Last Friday The Wall Street Journal reported that Caremark Rx (NYSE:CMX) was close to a deal to pay $100 million to settle with the Justice Department over how Caremark controls pharmacy benefits. The stock spiked on Friday and then fell back before the close, and today it appears to be shedding gains it made yesterday. Marketwatch reported yesterday that the "Department of Justice is joining several other states in a whistleblower lawsuit alleging pharmacy benefits manager Caremark Rx Inc. did not appropriately repay Medicaid and other federal health insurance programs."

C.R. Bard (NYSE:BCR) is down today, continuing an obdurate decline that began when the stock hit an all-time high on May 9. The New Jersey company makes medical products, and has a distinguished history; Hoovers tells me that it introduced the Foley urological catheter as long ago as 1934. The stock gapped down this morning, on no particular news that we can uncover, and found support at the 67 level. On May 18, Standard & Poor's Ratings Services placed long-term and short-term ratings for BCR on review, thanks to the company's ability to generate cash flows "well in excess of ongoing needs," and suggested that a further rating upgrade within the next few months might be appropriate.

And finally... rumor has it that Google (GOOG) might join the S&P 500 Index soon. That's going to make this column easy to write. I could even automate the process, with a Word macro that inserts the text: "Hit yet another all-time high."

Click the following link to see a Chart of the SPX 500 Index's Top-20 Percentage Gainers: http://www.schaeffersresearch.com/wire?ID=13309 .

Click the following link to see a Chart of the SPX 500 Index's Top-20 Percentage Losers: http://www.schaeffersresearch.com/wire?ID=13309 .

Take advantage of the timely Schaeffer commentaries by signing up for their free e-newsletters -- Opening View, Market Recap and Monday Morning Outlook. Click here to have the Schaeffer's commentaries delivered to you free via email every day. http://www.schaeffersresearch.com/redirect.aspx?CODE=PRSHS1M&PAGE=1 .

About Schaeffer's Investment Research (www.SchaeffersResearch.com)

Schaeffer's Investment Research, founded by Bernie Schaeffer in 1981, is a financial information and trading resources company. It publishes Bernie Schaeffer's Option Advisor, the nation's leading options subscription newsletter. The firm's contrarian approach focuses on stocks with technical and fundamental trends that run counter to investor expectations. The firm's website, http://www.SchaeffersResearch.com , is recognized as one of the leading information sources for stock and options traders and was cited as the top options website by both Forbes and Barron's. Click here for more details about Schaeffer's trading methodology: http://www.SchaeffersResearch.com/method .